Concepedia

LBA31 Primary results from IMagyn050/GOG 3015/ENGOT-OV39, a double-blind placebo (pbo)-controlled randomised phase III trial of bevacizumab (bev)-containing therapy +/- atezolizumab (atezo) for newly diagnosed stage III/IV ovarian cancer (OC)

Kathleen N. Moore, Michael A. Bookman, Jalid Sehouli, Austin Miller, Charles Anderson, Giovanni Scambia, Tashanna Myers, Katina Robison, Johanna Mäenpää, Lyndsay Willmott,

Annals of Oncology · 2020 · 36 citations · 0 references

DOI

Concepts